Britt Hanson

701 total citations
19 papers, 511 citations indexed

About

Britt Hanson is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Britt Hanson has authored 19 papers receiving a total of 511 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Pathology and Forensic Medicine and 3 papers in Surgery. Recurrent topics in Britt Hanson's work include Lymphoma Diagnosis and Treatment (4 papers), Muscle Physiology and Disorders (3 papers) and Prenatal Screening and Diagnostics (3 papers). Britt Hanson is often cited by papers focused on Lymphoma Diagnosis and Treatment (4 papers), Muscle Physiology and Disorders (3 papers) and Prenatal Screening and Diagnostics (3 papers). Britt Hanson collaborates with scholars based in United Kingdom, United States and South Africa. Britt Hanson's co-authors include Matthew J. A. Wood, Thomas C. Roberts, David H. Vesole, Chadi Nabhan, Stephanie Gregory, Reem Karmali, Annette K. Larsen, Scott E. Smith, Andrew M. Evens and Erika Ramsdale and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Britt Hanson

17 papers receiving 503 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Britt Hanson United Kingdom 11 242 168 103 88 68 19 511
Bariş Boyraz United States 12 277 1.1× 57 0.3× 134 1.3× 46 0.5× 50 0.7× 27 619
Yong Yu China 14 200 0.8× 122 0.7× 130 1.3× 19 0.2× 90 1.3× 55 483
Tomoaki Wada Japan 15 310 1.3× 141 0.8× 179 1.7× 18 0.2× 75 1.1× 35 610
Jason H. Kurzer United States 13 233 1.0× 49 0.3× 182 1.8× 23 0.3× 52 0.8× 28 633
De Fen Shen United States 15 132 0.5× 191 1.1× 146 1.4× 206 2.3× 23 0.3× 36 659
Satoru Komaki Japan 12 154 0.6× 38 0.2× 49 0.5× 55 0.6× 29 0.4× 35 394
R. Serafini Italy 13 474 2.0× 139 0.8× 239 2.3× 31 0.4× 47 0.7× 29 888
Ashwini Yenamandra United States 9 363 1.5× 48 0.3× 107 1.0× 19 0.2× 65 1.0× 21 523
Míriam Méndez Spain 12 245 1.0× 63 0.4× 168 1.6× 19 0.2× 154 2.3× 54 528
Maryse Baia France 10 113 0.5× 270 1.6× 251 2.4× 53 0.6× 28 0.4× 12 612

Countries citing papers authored by Britt Hanson

Since Specialization
Citations

This map shows the geographic impact of Britt Hanson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Britt Hanson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Britt Hanson more than expected).

Fields of papers citing papers by Britt Hanson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Britt Hanson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Britt Hanson. The network helps show where Britt Hanson may publish in the future.

Co-authorship network of co-authors of Britt Hanson

This figure shows the co-authorship network connecting the top 25 collaborators of Britt Hanson. A scholar is included among the top collaborators of Britt Hanson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Britt Hanson. Britt Hanson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Ning, Feng, Nenad Svrzikapa, Yan Dai, et al.. (2025). Targeted BDNF upregulation via upstream open reading frame disruption. Molecular Therapy. 34(3). 1652–1671.
2.
Hanson, Britt, Joseph Shaw, Elizabeth Young, et al.. (2024). Expanding Access to Noninvasive Prenatal Diagnosis for Monogenic Conditions to Consanguineous Families. Clinical Chemistry. 70(5). 727–736. 1 indexed citations
3.
Ahlskog, Nina, Nenad Svrzikapa, Yahya E. Jad, et al.. (2024). uORF-targeting steric block antisense oligonucleotides do not reproducibly increase RNASEH1 expression. Molecular Therapy — Nucleic Acids. 36(1). 102406–102406. 4 indexed citations
4.
Hanson, Britt, Wenyi Zheng, Mariana Conceição, et al.. (2023). EV-mediated promotion of myogenic differentiation is dependent on dose, collection medium, and isolation method. Molecular Therapy — Nucleic Acids. 33. 511–528. 13 indexed citations
5.
Hanson, Britt, et al.. (2023). Non-invasive prenatal diagnosis (NIPD): current and emerging technologies. PubMed. 4(1). 3–26. 5 indexed citations
6.
Hanson, Britt, Nina Ahlskog, Nenad Svrzikapa, et al.. (2022). Non-uniform dystrophin re-expression after CRISPR-mediated exon excision in the dystrophin/utrophin double-knockout mouse model of DMD. Molecular Therapy — Nucleic Acids. 30. 379–397. 11 indexed citations
7.
Hanson, Britt, Elizabeth Scotchman, Lyn S. Chitty, & Natalie Chandler. (2022). Non-invasive prenatal diagnosis (NIPD): how analysis of cell-free DNA in maternal plasma has changed prenatal diagnosis for monogenic disorders. Clinical Science. 136(22). 1615–1629. 25 indexed citations
8.
Hanson, Britt, Matthew J. A. Wood, & Thomas C. Roberts. (2021). Molecular correction of Duchenne muscular dystrophy by splice modulation and gene editing. RNA Biology. 18(7). 1048–1062. 31 indexed citations
9.
Hanson, Britt, et al.. (2020). Application of CRISPR-Cas9-Mediated Genome Editing for the Treatment of Myotonic Dystrophy Type 1. Molecular Therapy. 28(12). 2527–2539. 21 indexed citations
10.
Johansson, Henrik J., Britt Hanson, Anna Coenen-Stass, et al.. (2020). Mutation-independent Proteomic Signatures of Pathological Progression in Murine Models of Duchenne Muscular Dystrophy. Molecular & Cellular Proteomics. 19(12). 2047–2068. 25 indexed citations
11.
Hanson, Britt, et al.. (2019). Isolated testicular vasculitis due to immune checkpoint inhibitor. SHILAP Revista de lepidopterología. 7(1). 35–36. 7 indexed citations
12.
Hensing, Thomas A., et al.. (2019). Response rate to chemotherapy after disease progression with anti-PD-1/PD-L1 in metastatic cancer.. Journal of Clinical Oncology. 37(15_suppl). e14088–e14088. 2 indexed citations
13.
Coenen-Stass, Anna, Britt Hanson, Mariana Conceição, et al.. (2019). Extracellular microRNAs exhibit sequence-dependent stability and cellular release kinetics. RNA Biology. 16(5). 696–706. 60 indexed citations
14.
Kraberger, Simona, S. Saumtally, Dionne N. Shepherd, et al.. (2017). Molecular diversity, geographic distribution and host range of monocot-infecting mastreviruses in Africa and surrounding islands. Virus Research. 238. 171–178. 10 indexed citations
15.
Hanson, Britt. (2016). Necroptosis: A new way of dying?. Cancer Biology & Therapy. 17(9). 899–910. 69 indexed citations
16.
Evens, Andrew M., Irene Helenowski, Chadi Nabhan, et al.. (2011). Multicenter Analysis of Elderly Hodgkin Lymphoma (eHL): Outcomes and Prognostic Factors in the Modern Era. Blood. 118(21). 2625–2625.
17.
Nabhan, Chadi, Sonali M. Smith, Irene Helenowski, et al.. (2011). Analysis of very elderly (≥80 years) non‐hodgkin lymphoma: impact of functional status and co‐morbidities on outcome. British Journal of Haematology. 156(2). 196–204. 77 indexed citations
18.
Evens, Andrew M., Irene Helenowski, Erika Ramsdale, et al.. (2011). A retrospective multicenter analysis of elderly Hodgkin lymphoma: outcomes and prognostic factors in the modern era. Blood. 119(3). 692–695. 111 indexed citations
19.
Hanson, Britt & David H. Vesole. (2009). Retaspimycin hydrochloride (IPI-504): a novel heat shock protein inhibitor as an anticancer agent. Expert Opinion on Investigational Drugs. 18(9). 1375–1383. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bariş Boyraz Breakdown of academic impact, for papers by Yong Yu Breakdown of academic impact, for papers by Tomoaki Wada Breakdown of academic impact, for papers by Jason H. Kurzer Breakdown of academic impact, for papers by De Fen Shen Breakdown of academic impact, for papers by Satoru Komaki Breakdown of academic impact, for papers by R. Serafini Breakdown of academic impact, for papers by Ashwini Yenamandra Breakdown of academic impact, for papers by Míriam Méndez Breakdown of academic impact, for papers by Maryse Baia
Rankless by CCL
2026